Modelling the Impact and Cost-Effectiveness of Extended Screening and Treatment with Direct-Acting Antivirals in a Swiss Custodial Setting

Girardin, François; Hearmon, Natalie; Castro, Erika; Negro, Francesco; Eddowes, Lucy; Getaz, Laurent; Wolff, Hans

doi:10.1093/cid/ciz088

Advanced search

Browse by...

Deposit

Highlights

More informations

Title		Modelling the Impact and Cost-Effectiveness of Extended Screening and Treatment with Direct-Acting Antivirals in a Swiss Custodial Setting
Authors		Girardin, François Hearmon, Natalie Castro, Erika Negro, Francesco Eddowes, Lucy Getaz, Laurent Wolff, Hans
Published in		Clinical infectious diseases. 2019
Abstract		Hepatitis C virus (HCV) amongst people living in detention (PLD) is typically high in many countries including Switzerland, where it is estimated that the HCV prevalence rate is between 5.7% and 6.2%. In Switzerland, the existing screening strategy involves routine screening of PLD who indicate they are from HCV high-risk populations based on questionnaire responses upon entry to the detention center, rather than an offer to screen all PLD.
Keywords		Cost-Benefit Analysis — Hepatitis C — Mass Screening — Prisons — Antiviral Agents
Identifiers		DOI: 10.1093/cid/ciz088 PMID: 30715266
Full text		Article (Accepted version) (761 Kb) - Free access
Structures		Faculté de médecine / Section de médecine clinique / Département de médecine Faculté de médecine / Section de médecine clinique / Département d'anesthésiologie, pharmacologie, soins intensifs et urgences Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires
Research groups		Etudes et traitement de l'hépatite C et B (554) Groupe Desmeules Jules (pharmacologie/toxicologie) (567)
Citation (ISO format)		GIRARDIN, François et al. Modelling the Impact and Cost-Effectiveness of Extended Screening and Treatment with Direct-Acting Antivirals in a Swiss Custodial Setting. In: Clinical Infectious Diseases, 2019. doi: 10.1093/cid/ciz088 https://archive-ouverte.unige.ch/unige:115852